Bivalirudin 70436-0025-82
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Suspension
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 30, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA213078
Need to source Bivalirudin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bivalirudin | 250 mg/1 |
Drug Class
Anti-coagulant [EPC]Direct Thrombin Inhibitor [EPC]Anti-coagulant [EPC]
Selected Package
70436-0025-82Selected10 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 CARTON (70436-025-82)
Other packages for this product(1)
1 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 VIAL, SINGLE-DOSE (70436-025-80)